Clinical trial protocols of repurposed prophylaxis for COVID-19: A review
نویسندگان
چکیده
منابع مشابه
Chemoprophylatic. Ayurvedic, Homeopathic and Unani approaches for COVID-19 prophylaxis
There are no specific therapies approved by the U.S. FDA for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 COVID-19. Several agents are under clinical trial and the use of pharmacological agents are based on in vitro activity against SARS-CoV-2 or related viruses. While the efficacy of drug therapy is yet to be established, we need ...
متن کاملA Review of Pharmacotherapy for Coronavirus Disease 2019 (COVID-19)
The epidemic of COVID-19 and its associated acute respiratory syndrome has posed an unprecedented challenge in identifying effective drugs to prevent and treat it. Due to the high prevalence of this disease and the high number of people at risk, medical staff needs accurate evidence regarding effective drug treatments for this infection. There is currently no effective treatment for COVID-19. B...
متن کاملHydroxychloroquine: A bridge prophylaxis till finding the COVID-19 vaccine
Regarding the importance of COVID-19 pandemic and risks that the infection imposes on healthcare workers, this manuscript discusses the potential usage of Hydroxychloroquine as a prophylactic agent.
متن کاملIdiosyncrasies of COVID-19; A Review
The Coronavirus disease 2019, identified by Chinese researchers to be the caused by a novel enveloped betacoronavirus, Severe Acute Respiratory Syndrome Coronavirus- 2 which was first isolated in Wuhan, China has been declared a global pandemic by the world health organization. The virus has several structural proteins that contributed to its pathogenesis such as spikes, membrane, envelop and n...
متن کاملEffect of Statin Treatment on COVID-19 Patients’ Outcomes: A Randomized Double-blind Controlled Clinical Trial
Background: Statins may be protective against viral infection and have been suggested for the treatment of coronavirus disease 2019 (COVID-19). Objective: In this study, we aimed to evaluate the effect of atorvastatin on COVID-19 patients. Methods: Our study is a randomized double-blind controlled clinical trial that constitutes a population of COVID-19 patients admitted to Bu-Ali Sina Hospi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Infectious Diseases Now
سال: 2021
ISSN: 2666-9919
DOI: 10.1016/j.medmal.2020.09.013